In reply

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 379-380

  Vora, Neeta L ^a,b   O'Brien, Barbara M ^c,d,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Maternal Serum Screening Laboratory   (United States)

^c Department of Obstetrics and Gynecology Women and Infant's Hospital   (United States)

^d Prenatal Diagnosis Center   (United States)

^e Dept of Obstetrics and Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED PRACTICE; GENE DELETION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; HUMAN; INFORMED CONSENT; LETTER; MICROARRAY ANALYSIS; MICRODELETION; MICRODELETION SYNDROME; NON INVASIVE PROCEDURE; OBSTETRICIAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TRISOMY; TRISOMY 16; TRISOMY 22; BLOOD; FEMALE; FETAL DISEASES; GENETICS; PREGNANCY;

DNA;

DNA; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84905028724     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000401     Document Type: Letter

References (2)

1. Vora NL, O'Brien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014;123:1097-99.
2. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58:1148-51.